The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending goes into effect.

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

The Inflation Reduction Act of 2022 included significant changes ... The $2,000 cap does not include premiums associated with the Medicare drug plan. It applies only to prescriptions covered ...

As of October 2022, Vascepa had coverage without restrictions for more than 90% of Medicare Part D enrollees, according to its manufacturer. According to Optum Perks, 30 capsules of Vascepa cost as ...

Trump rescinded Executive Order 14087, "Lowering Prescription Drug Costs for Americans," which directed Medicare and Medicaid ...